ISRCTN48682427
Completed
Not Applicable
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trial
Ministry of Health (Brazil)0 sites0 target enrollmentMarch 2, 2004
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ministry of Health (Brazil)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. HIV\-1 infected individuals
- •2\. 18 years old or older
- •3\. Starting antiretroviral therapy in three AIDS clinics in Porto Alegre (Brazil)
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
Active, not recruiting
Phase 1
Initiation of first-line antiretroviral treatment with TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the first clinical contact in France: Trial IMEA 055 – FASTHIV positive age > 18 years -newly diagnosed HIV-infected individual evidenced by any tests -antiretroviral-treatment naive -negative urine pregnancy test -willing to sign an informed written consent– -regular health insurance -willing to provide two distinct contact information (telephone number and/or email) in order to be easily reached if needed between Day 0 and Day 7Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2019-000812-27-FRIMEA110
Completed
Not Applicable
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patientsHIV infectionInfections and InfestationsHIVISRCTN22114173Institute of Community Medicine, University of Tromsø (Norway)100
Not yet recruiting
Phase 1
Immunological and Virucidal effect of Amrita Tablet for Prevention of HIV AIDSCTRI/2024/01/062079Satyananda yoga and Ayurveda Research institute Motihari
Active, not recruiting
Phase 1
Short pulse antiretroviral therapy at HIV seroconversion:A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection. Tratamiento antirretroviral en pulsos cortos en la seroconversión por el VIH: ensayo clínico aleatorizado, multicéntrico, de intervención terapéutica en la infección primaria por VIH-1. - SPARTACprimary HIV infection infección primaria por el VIHMedDRA version: 9.1 Level: LLT Classification code 10058427 Term: Primary HIV infectionEUCTR2004-000446-20-ESImperial College371